FDA grapples with China biotech's rise across the agency
WASHINGTON — What do you do when an economic rival swiftly becomes a critical player in the industry you regulate? The FDA is coming to grips with this question right now, and two of its senior ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.